Литература

1.      2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 2019. doi/10.1093/eurheartj/ehz455.

2.      Диагностика и коррекция нарушений липидного обмена с целью профилактики и лечения атеросклероза. Российские рекомендации

VI пересмотр. Атеросклероз и дилипидемии.2017;3:5-22.

3.      Catapano A., Graham I., De Backer G., at al. 2016 ESC/EAS Guidelines for the Management of  Dyslipidaemias The Task Force for the Management of Dyslipidaemias of the ESC and EAS. 2016. European Heart Journal, doi:10.1093/eurheartj/ehw272.

4.      Goff D., Lloyd-Jones D., Bennett G., at al.  2013 ACC/AHA Guideline on the Assessment of  Cardiovascular Risk. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014. Journal of the American College of Cardiology, 63(25), doi.org/10.1016/j.jacc.

5.      Piepoli M., Hoes A., Agewall S., at al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. European Heart Journal. 2016;37:2315–2381.